-
1
-
-
0028295893
-
Current treatment modalities for hepatocellular carcinoma
-
DG Farmer MH Rosove A Shaked 1994 Current treatment modalities for hepatocellular carcinoma Ann Surg 219 236 247
-
(1994)
Ann Surg
, vol.219
, pp. 236-247
-
-
Farmer, D.G.1
Rosove, M.H.2
Shaked, A.3
-
2
-
-
0036096420
-
Hepatocellular carcinoma: Diagnosis and treatment
-
AS Befeler AM Di Bisceglie 2002 Hepatocellular carcinoma: diagnosis and treatment Gastroenterology 122 1609 1619
-
(2002)
Gastroenterology
, vol.122
, pp. 1609-1619
-
-
Befeler, A.S.1
Di Bisceglie, A.M.2
-
3
-
-
0034786583
-
Ablative techniques for hepatocellular carcinoma
-
CC Barnett SA Curley 2001 Ablative techniques for hepatocellular carcinoma Semin Oncol 28 487 496
-
(2001)
Semin Oncol
, vol.28
, pp. 487-496
-
-
Barnett, C.C.1
Curley, S.A.2
-
4
-
-
0027584709
-
Hepatocellular carcinoma with portal tumor thrombus: Analysis of factors determining prognosis
-
T Fujii K Takayasu Y Muramatsu 1993 Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis Jpn J Clin Oncol 23 105 109
-
(1993)
Jpn J Clin Oncol
, vol.23
, pp. 105-109
-
-
Fujii, T.1
Takayasu, K.2
Muramatsu, Y.3
-
5
-
-
0031911767
-
Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: Proposal as a standard therapy
-
I Ikai Y Yamaoka Y Yamamoto 1998 Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy Ann Surg 227 433 439
-
(1998)
Ann Surg
, vol.227
, pp. 433-439
-
-
Ikai, I.1
Yamaoka, Y.2
Yamamoto, Y.3
-
6
-
-
0035119043
-
Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein
-
J Fan ZQ Wu ZY Tang 2001 Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein World J Gastroenterol 7 28 32
-
(2001)
World J Gastroenterol
, vol.7
, pp. 28-32
-
-
Fan, J.1
Wu, Z.Q.2
Tang, Z.Y.3
-
7
-
-
0032898237
-
Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
-
JM Llovet J Bustamante A Castells 1999 Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 62 67
-
(1999)
Hepatology
, vol.29
, pp. 62-67
-
-
Llovet, J.M.1
Bustamante, J.2
Castells, A.3
-
8
-
-
85047689984
-
Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: A need for reclassification
-
RT Poon ST Fan IO Ng 2003 Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification Ann Surg 237 376 383
-
(2003)
Ann Surg
, vol.237
, pp. 376-383
-
-
Poon, R.T.1
Fan, S.T.2
Ng, I.O.3
-
9
-
-
0037080269
-
Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
-
M Sakon H Nagano K Dono 2002 Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches Cancer 94 435 442
-
(2002)
Cancer
, vol.94
, pp. 435-442
-
-
Sakon, M.1
Nagano, H.2
Dono, K.3
-
10
-
-
26944439521
-
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combination of subcutaneous interferon-α and intraarterial 5-fluorouracil: Role of expression of type 1 interferon receptor
-
H Ota H Nagano M Sakon 2005 Treatment of hepatocellular carcinoma with major portal vein thrombosis by combination of subcutaneous interferon-α and intraarterial 5-fluorouracil: role of expression of type 1 interferon receptor Br J Cancer 93 557 564
-
(2005)
Br J Cancer
, vol.93
, pp. 557-564
-
-
Ota, H.1
Nagano, H.2
Sakon, M.3
-
11
-
-
34047129082
-
Hepatic resection followed by IFN-α and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch
-
(in press)
-
Nagano H, Sakon M, Eguchi H, et al. Hepatic resection followed by IFN-α and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology (in press)
-
Hepatogastroenterology
-
-
Nagano, H.1
Sakon, M.2
Eguchi, H.3
-
12
-
-
0036307911
-
Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein
-
T Itamoto H Nakahara H Tashiro 2002 Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein J Surg Oncol 80 143 148
-
(2002)
J Surg Oncol
, vol.80
, pp. 143-148
-
-
Itamoto, T.1
Nakahara, H.2
Tashiro, H.3
-
13
-
-
0026071402
-
Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression
-
DW Shen YG Lu KV Chin 1991 Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression J Cell Sci 98 317 322
-
(1991)
J Cell Sci
, vol.98
, pp. 317-322
-
-
Shen, D.W.1
Lu, Y.G.2
Chin, K.V.3
-
14
-
-
0031612291
-
Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma
-
T Urabe S Kaneko E Matsushita 1998 Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma Oncology 55 39 47
-
(1998)
Oncology
, vol.55
, pp. 39-47
-
-
Urabe, T.1
Kaneko, S.2
Matsushita, E.3
-
15
-
-
0037315472
-
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma
-
YZ Patt MM Hassan RD Lozano 2003 Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma J Clin Oncol 21 421 427
-
(2003)
J Clin Oncol
, vol.21
, pp. 421-427
-
-
Patt, Y.Z.1
Hassan, M.M.2
Lozano, R.D.3
-
16
-
-
0026600296
-
Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells
-
EL Schwartz M Hoffman CJ O'Connor 1992 Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells Biochem Biophys Res Commun 182 1232 1239
-
(1992)
Biochem Biophys Res Commun
, vol.182
, pp. 1232-1239
-
-
Schwartz, E.L.1
Hoffman, M.2
O'Connor, C.J.3
-
17
-
-
0031105022
-
Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells
-
CL van der Wilt K Smid GW Aherne 1997 Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells Eur J Cancer 33 471 478
-
(1997)
Eur J Cancer
, vol.33
, pp. 471-478
-
-
Van Der Wilt, C.L.1
Smid, K.2
Aherne, G.W.3
-
18
-
-
0033941539
-
Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells
-
H Eguchi H Nagano H Yamamoto 2000 Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells Clin Cancer Res 6 2881 2890
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2881-2890
-
-
Eguchi, H.1
Nagano, H.2
Yamamoto, H.3
-
19
-
-
9744276046
-
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against hepatocellular carcinoma
-
T Yamamoto H Nagano M Sakon 2004 Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against hepatocellular carcinoma Clin Cancer Res 10 7884 7895
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7884-7895
-
-
Yamamoto, T.1
Nagano, H.2
Sakon, M.3
-
20
-
-
19944430939
-
Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells
-
M Kondo H Nagano H Wada 2005 Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells Clin Cancer Res 11 1277 1286
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1277-1286
-
-
Kondo, M.1
Nagano, H.2
Wada, H.3
-
21
-
-
0034223548
-
Expression of interferon alpha/beta receptor in human hepatocellular carcinoma
-
M Kondo H Nagano M Sakon 2000 Expression of interferon alpha/beta receptor in human hepatocellular carcinoma Int J Oncol 17 83 88
-
(2000)
Int J Oncol
, vol.17
, pp. 83-88
-
-
Kondo, M.1
Nagano, H.2
Sakon, M.3
|